ALFApump System Post Marketing Surveillance Registry (2011-AAR-004)

Sequana Medical

Status: Completed

Conditions: Refractory Ascites; Liver Cirrhosis; Malignant Ascites

Study type: Observational

Funder types: Industry

Identifiers

NCT01532427

2011-AAR-004

Details and patient eligibility

About

This is a post market surveillance registry to monitor the safety and performance of the ALFApump system.

Enrollment: 100 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Refractory or recurrent ascites and liver cirrhosis or malignancy
• written informed consent

Exclusion criteria

• < 18 years
• pregnant
• not able to use the Smart charger